Duggan Robert Picked Pulse Biosciences Inc(NASDAQ:PLSE) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Pulse Biosciences Inc. (NASDAQ:PLSE) reported that Duggan Robert W has picked up 2,578,950 of common stock as of 2017-04-11.
The acquisition brings the aggregate amount owned by Duggan Robert W to a total of 2,578,950 representing a 18.2% stake in the company.
For those not familiar with the company, Pulse Biosciences, Inc., formerly Electroblate, Inc., is a development-stage medical device company using a platform technology called Nano-Pulse Electro-Signaling (NPES). NPES is a local and drug-free technology that utilizes nanosecond pulsed electric fields to induce cell signaling and the activation of cellular pathways in tissue. NPES provides treatment in a range of dermatology and aesthetic applications. It offers treatment for minimally invasive applications, such as cardiac ablation, lung disease, Barret’s esophagus, thyroid nodules, and ear, nose and throat (ENT) papillomas. The Company is developing a system for the delivery of NPES treatments, identified as the PulseTx system (PulseTx). The PulseTx system delivers NPES pulses through its tunable pulse generator and its planned suite of electrodes. The PulseTx system pulses are applied directly to tissue through electrodes, creating transient nanometer pores in cell and organelle membranes.
A glance at Pulse Biosciences Inc. (NASDAQ:PLSE)’s key stats reveals a current market capitalization of 351.73 Million based on 14.14 Million shares outstanding and a price at last close of $23.18 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-04-10, Duggan picked up 22,764 at a purchase price of $21.40. This brings their total holding to 2,578,950 as of the date of the filing.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Pulse Biosciences Inc. (NASDAQ:PLSE) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Here’s Who Just Picked Up Echo Therapeutics Inc. (NASDAQ:ECTE) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Echo Therapeutics Inc. (NASDAQ:ECTE) reported that Schoenbart Alan Wayne has picked up 774,500 of common stock as of 2017-04-06.
The acquisition brings the aggregate amount owned by Schoenbart Alan Wayne to a total of 774,500 representing a 5.6% stake in the company.
For those not familiar with the company, Echo Therapeutics, Inc. is a medical device company. The Company is engaged in developing a non-invasive, wireless continuous glucose monitoring (CGM) system with use in the wearable-health consumer market, diabetes outpatient market and in the hospital setting. The Company operates through the development of transdermal skin permeation and diagnostic medical devices segment. The Company has also developed its needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose, enhanced delivery of topical pharmaceuticals and other applications. The CGM System includes a skin preparation device, transdermal glucose sensor, battery and wireless transmitter. The Company has conducted several human feasibility clinical studies with its CGM System in healthy subjects, diabetics and critically ill patients, as well as a clinical study at several hospitals in the United States.
A glance at Echo Therapeutics Inc. (NASDAQ:ECTE)’s key stats reveals a current market capitalization of 1.68 Million based on 12.00 Million shares outstanding and a price at last close of $0.140 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-20-20, Schoenbart picked up 2,500 at a purchase price of $1.44. This brings their total holding to 2,500 as of the date of the filing.
On the sell side, the most recent transaction saw Young unload 10,000 shares at a sale price of $2.38. This brings their total holding to 160,874.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Echo Therapeutics Inc. (NASDAQ:ECTE) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Voce Capital is Buying Cutera Inc. (NASDAQ:CUTR) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Cutera Inc. (NASDAQ:CUTR) reported that Voce Capital has picked up 477,031 of common stock as of 2017-03-22.
The acquisition brings the aggregate amount owned by Voce Capital to a total of 477,031 representing a 3.4% stake in the company.
For those not familiar with the company, Cutera, Inc. is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers. Each of its laser and other energy-based platforms consists of one or more hand pieces and a console that incorporates a universal graphical user interface, a laser or other energy-based module, control system software and high voltage electronics. enlighten is a dual wavelength (1,064 nanometer + 532 nanometer) and dual pulse duration (750 picosecond (ps) and 2 nanosecond (ns)) laser system. excel V is a vascular and benign pigmented lesion treatment platform designed for the core-market of dermatologists and plastic surgeons.
A glance at Cutera Inc. (NASDAQ:CUTR)’s key stats reveals a current market capitalization of 271.31 Million based on 13.87 Million shares outstanding and a price at last close of $20.30 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2012-08-21, Connors picked up 7,000 at a purchase price of $7.35. This brings their total holding to 610,971 as of the date of the filing.
On the sell side, the most recent transaction saw Plants unload 250,000 shares at a sale price of $20.25. This brings their total holding to 477,031.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Cutera Inc. (NASDAQ:CUTR) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.